Categories
Health

For Older Adults, Residence Care Has Develop into Tougher to Discover

The franchisees employ around 7,000 home care workers, most of them over 55 years of age. “We would like to add an additional 1,000 to 1,500 caregivers through this program,” said Namrata Yocom-Jan, company president.

In east Tennessee, where Ray Bales runs two Seniors Helping Seniors franchises, 11 people applied in a week after promoting $ 200 in bonuses on Facebook, he said. He hopes to attract 30 to 40 new workers. (No one objected to funding the company’s philanthropy with $ 50 from their potential bonuses, he said.)

But bonuses may not keep newcomers working in an area with notoriously high turnover – more than 80 percent in 2018, the Home Care Association found. Since then, sales have fallen; nevertheless, two thirds of the agency employees leave the company every year.

Some helpers take advantage of higher wages in retail, fast food, and other industries. Others have moved to independent work, avoiding intermediaries who pocket at least half of what customers pay for.

Wendy Gullickson, a licensed practical nurse in Wellfleet, Massachusetts, only spent a few months as a $ 13-hour agency before discovering she could make $ 25 as a private assistant – still less than local agencies charge. (Home care averaged $ 23 to 24 an hour across the country last year, but it was $ 29 to 30 in Massachusetts.)

For advocates, therefore, the key to attracting new home care workers is no secret. “What they need is a competitive wage because they can earn as much or more in other full-time sectors,” said Robert Espinoza, vice president of policy at PHI.

In 2018, the country’s estimated 2.8 million domestic helpers, most of them black women and about a third immigrants, earned an average of $ 12 an hour and $ 17,200 a year. Very few received benefits; more than half relied on grocery stamps, Medicaid, or other public aid.

Categories
Health

The Pfizer and Moderna vaccines are 94 % efficient at stopping hospitalization in older adults, a examine finds.

Pfizer BioNTech and Moderna coronavirus vaccines prevent 94 percent hospitalization of fully vaccinated adults aged 65 and over, according to a small study published Wednesday by the Centers for Disease Control and Prevention.

The results, which are in line with clinical trial results, are the first real evidence from the US that the vaccines protect against severe Covid-19. Older adults are at the highest risk of being hospitalized and dying from the disease. More than 573,000 people have died from the virus across the country, according to a New York Times database. As of Wednesday, 142.7 million people had received at least one dose of one of three federally approved vaccines, including about 98 million people who were fully vaccinated.

“These results are encouraging and welcome news for two-thirds of people 65 and older who are already fully vaccinated,” said Dr. Rochelle Walensky, CDC director, in a statement. “Covid-19 vaccines are highly effective and these real world results confirm the benefits of clinical trials preventing hospitalizations among the most vulnerable.”

The study is based on data from 417 patients enrolled in 24 hospitals in 14 states between January 1 and March 26. About half were 75 years or older.

Both the Pfizer and Moderna vaccines require two shots three to four weeks apart. Older adults who were partially vaccinated – that is, received a dose of the vaccine more than two weeks earlier – were 64 percent less likely to be hospitalized with the coronavirus than unvaccinated seniors, the researchers reported.

The vaccines did not reduce hospitalization rates in people who received their first dose less than two weeks earlier. It takes time for the body to build an effective immune response, and people are considered fully vaccinated two weeks after the last dose in the series.

“This also underscores the persistent risk of serious illness shortly after vaccination, before a protective immune response has been achieved, and increases the need for vaccinated adults to continue physical distancing and prevention behaviors,” the scientists wrote.

Categories
Business

Surgeon says pausing J&J vaccine for youthful populations is sensible, however could possibly be lifted for older age teams

Dr. Atul Gawande said he “thinks something special is going on here” when it comes to blood clotting and Johnson & Johnson’s Covid-19 single-dose vaccine.

“We have an unusual type of clotting syndrome, very specific to these vaccines, in women in the younger age group, and it’s not like the other cases where these rare incidents happen. I think there are probably adenovirus vaccines. A some risk for this rare disease, which is increased in a certain age group, “said Gawande.

Experts from a panel of the Centers for Disease Control and Prevention decided to postpone a decision on the use of J & J’s single-dose Covid vaccine on Wednesday. They found they needed more time to assess the data and risks.

The meeting comes a day after federal health officials advised the US to temporarily suspend use of J & J’s single-dose vaccine as a “caution” after six women out of approximately 6.9 million people who received the shot reported getting heavy blood clots. Due to the postponement of the vote, the pause remains in force for the time being.

Gawande, a surgeon and professor at TH Chan School of Public Health at Harvard, said he thought the J&J vaccine hiatus made sense for younger populations, and he also thought it could be lifted for older age groups.

“I think there is enough information to know that this is safe for people over 50 and I think they could possibly have left the break for the older age group,” Gawande said on CNBC’s “The News with Shepard Smith” . “I think this could end up here like you saw for AstraZeneca in Europe.”

More than 7.2 million J&J doses have been administered nationwide, and the vaccine is responsible for 9.5% of the roughly 75 million Americans who are fully vaccinated, according to CDC data.

Gawande noted that the Moderna and Pfizer vaccine supply can be used to contain the increase in cases in states in the United States. He told host Shepard Smith that he was in favor of increasing the second dose of the Moderna and Pfizer vaccines to two, four, six weeks “in order to double the number of people currently vaccinated.

Categories
Business

Texas opens Covid vaccine eligibility to individuals 50 and older because it lifts masks mandate

Ron Votral will receive a vaccine against coronavirus disease (COVID-19) at a drive-through vaccination site in Robstown, Texas on February 9, 2021.

Go Nakamura | Reuters

Texas residents 50 and older can get Covid-19 vaccines starting March 15. This is the most populous US state, which extends the eligibility to the previous age group, the state Department of Health said on Wednesday.

So far, Texas has given frontline health workers, people with underlying health conditions, and those 65 and over the opportunity to get a shot. The state announced last week that it would immediately add school and child carers to its list of vaccination entitlements.

By extending the eligibility to people over 50, the state wants to protect those most at risk of serious illnesses from the virus, the ministry said in a statement. The move will put 5 million more Texans on the state’s priority list, even though more than 1 million of them have already been vaccinated.

“The extension to ages 50-64 will continue the state’s priorities of protecting those at greatest risk of serious consequences and preserving the state’s health system,” said Imelda Garcia, deputy commissioner for the ministry of state Health services for laboratory and infectious diseases made a statement.

More than half of the state’s seniors have received at least one dose of vaccine, and nearly a third are fully vaccinated, according to DSHS.

Wednesday also marked the end of the Lone Star State’s mask mandate, and companies are now 100% allowed to reopen, Governor Greg Abbott announced last week, pointing to the increase in vaccine eligibility, the decrease in new cases and the state’s adequate hospital capacity Argumentation.

Alaska became the first state on Tuesday to allow residents 16 and older to be vaccinated.

Categories
Health

Lung Most cancers Scans Are Really useful for Folks 50 and Older With Shorter Smoking Histories

“There is evidence that a fairly simple, five-minute, low-dose, low-radiation scan can really save many lives,” said Dr. Bernard J. Park, pulmonary surgeon and clinical director of the lungs. Screening service at the Memorial Sloan Kettering Cancer Center in New York. Around 75 to 85 percent of the cancers found in this screening are in stage 1 and it is estimated that only surgery or radiation can be cured.

Dr. Park said that many people who signed up for screening had quit smoking or were trying to quit, but that some viewed clear scans as a sign that they could continue smoking.

Dr. Smith said the American Cancer Society should revise its own guidelines for lung cancer screening and that its advice would likely be similar to that of the task force.

In 2013, the American Academy of Family Physicians declined to recommend for or against CT screening for lung cancer because of insufficient evidence. But the President, Dr. Ada Stewart, in a statement emailed Monday, said the academy would review the task force’s new evidence and decide whether to update its own recommendation to its members.

There were 2.09 million new cases of lung cancer worldwide in 2018, and the disease is also the leading cause of cancer deaths according to the World Health Organization. That year 1.76 million people died.

According to the National Cancer Institute, there were 228,820 new cases of lung cancer in the U.S. in 2020, killing 135,720 people. About 90 percent of cases occur in people who smoke, and the current risk for smokers of developing the disease is about 20 times that of non-smokers.

Only about 20.5 percent of patients survive five years after diagnosis. Most cases are diagnosed late after the cancer has spread. But if it can be found and treated early, a cure is possible, doctors say.

Categories
Health

How Significant Is Prediabetes for Older Adults?

Several years ago, routine laboratory tests showed that Susan Glickman Weinberg, then a 65-year-old clinical social worker in Los Angeles, had a hemoglobin A1C value of 5.8 percent, which was barely above normal.

“This is considered to be prediabetes,” said her internist. A1C measures how much sugar has circulated in the bloodstream over time. If her results hit 6 percent – still below the number that defines diabetes (6.5) – her doctor said he would recommend the widely used drug metformin.

“The thought that I might get diabetes was very annoying,” recalled Ms. Weinberg, who, as a child, had heard relatives talk about “this mysterious terrible thing”.

She was already on two blood pressure drugs, a statin for cholesterol and an osteoporosis drug. Did she really need a different recipe? She was also concerned about reports of tainted imported drugs. She wasn’t even sure what prediabetes meant or how quickly it could turn into diabetes.

“I felt like Patient Zero,” she said. “There were a lot of unknowns.”

Now there are fewer strangers. A longitudinal study of older adults published online this month in the journal JAMA Internal Medicine provides some answers to the very common intermediate disease known as prediabetes.

The researchers found that older people who were alleged to be prediabetic were more likely to have blood sugar levels return to normal over several years than they were with diabetes. And they were no more likely to die during the follow-up period than their counterparts with normal blood sugar.

“For most older adults, prediabetes should probably not be a priority,” said Elizabeth Selvin, epidemiologist at the Johns Hopkins Bloomberg School of Public Health in Baltimore and lead author on the study.

Prediabetes, a condition rarely discussed 15 years ago, refers to blood sugar levels that are higher than normal but have not exceeded the threshold for diabetes. It is usually defined by a hemoglobin A1C value of 5.7 to 6.4 percent or a fasting glucose level of 100 to 125 mg / dL; By midlife, it can indicate serious health problems.

A diagnosis of prediabetes means you are more likely to get diabetes and “that it leads to downstream disease,” said Dr. Kenneth Lam, a geriatrician at the University of California at San Francisco and author of an editorial accompanying the study. “It damages your kidneys, your eyes and your nerves. It causes heart attacks and strokes, ”he said.

But for an older adult just reaching higher blood sugar levels, that’s a different story. It takes years for these dire consequences to develop, and many people in the 70s and 80s won’t live long enough to face them.

This fact sparked debates for years. Should older people with blood sugar levels slightly above average – a common occurrence as the pancreas produce less insulin later in life – take action, as the American Diabetes Association has called for?

Or does the prediabetic labeling merely “medicalize” a normal part of aging and create unnecessary anxiety for those already dealing with multiple health problems?

Dr. Selvin and her colleagues analyzed the results of an ongoing national cardiovascular risk study that began in the 1980s. When 3,412 of the participants showed up for their physical and laboratory tests between 2011 and 2013, they were 71 to 90 years old and did not have diabetes.

However, prediabetes was widespread. Almost three quarters qualified as prediabetic based on their A1C or fasting blood sugar levels.

These results echo a 2016 study that noted that a popular online risk test created by the Centers for Disease Control and Prevention and the American Diabetes Association called doihaveprediabetes.org was almost all over Classifies 60-year-olds as prediabetic.

In 2010, a CDC review found that 9 to 25 percent of patients with an A1C of 5.5 to 6 percent will develop diabetes over a five-year period. This also applies to 25 to 50 percent of those with A1C values ​​of 6 to 6.5. However, these estimates were based on a middle-aged population.

When Dr. Selvin and her team five to six years later looked at what had actually happened to their older prediabetic cohort, only 8 or 9 percent had developed diabetes, depending on the definition used.

A much larger group – 13 percent of those whose A1C levels were elevated and 44 percent of those with prediabetic fasting blood sugar – actually saw their readings return to normal blood sugar levels. (A Swedish study found similar results.)

16 to 19 percent had died, about as much as without prediabetes.

“We don’t see a great deal of risk in these people,” said Dr. Selvin. “Older adults can have complex health problems. Those that affect quality of life should be the focus, not the slightly elevated blood sugar. “

Dr. Saeid Shahraz, health researcher at Tufts Medical Center in Boston and lead author of the 2016 study, praised the new research. “The data is really strong,” he said. “The American Diabetes Association should do something about it.”

It may be, said Dr. Robert Gabbay, the ADA’s scientific and medical director. The organization is currently recommending “at least annual monitoring” for people with prediabetes, referral to lifestyle change programs that have been shown to reduce health risks, and possibly metformin for those who are obese and under 60.

Now the association’s Professional Practice Committee is going to review the study and “it could lead to some adjustments in the way we think about things,” said Dr. Gabbay. For older people who are considered to be prediabetic, “their risk may be lower than expected,” he added.

Defenders of the emphasis on the treatment of prediabetes, which allegedly affects a third of the US population, suggest that initial treatment should learn healthy behaviors that more Americans should be adopting anyway: weight loss, smoking cessation, exercise, and eating healthy .

“A number of patients have been diagnosed with prediabetes and that motivates them to change,” said Dr. Gabbay. “They know what to do, but they need something to get them going.”

Geriatrists tend to disagree. “It is unprofessional to mislead people and motivate them for fear of something that is not really true,” said Dr. Lam. “We’re all tired of having things to be scared of.”

He and Dr. Sei Lee, co-author of the lead article on the new study and a fellow geriatrician at the University of California at San Francisco, advocates a case-by-case approach in older adults – especially if they are diagnosed with prediabetes and their children scold them at every crack.

For a frail and vulnerable patient, “you are likely to be dealing with a variety of other problems,” said Dr. Lam. “Don’t worry about that number.”

A very healthy 75-year-old who could live another 20 years is faced with a more differentiated decision. You can never progress to diabetes; She may also already be following recommended lifestyle changes.

Ms. Weinberg, now 69, sought help from a nutritionist, changed her diet to emphasize complex carbohydrates and proteins, and started walking and climbing stairs more instead of taking elevators. She lost 10 pounds that she didn’t have to lose. Over 18 months, her barely increased A1C value fell to 5.6.

Her friend Carol Jacobi, 71, who also lives in Los Angeles, received a similar warning around the same time. Her A1C was 5.7, the lowest number defined as prediabetic, but her internist immediately prescribed metformin.

Ms. Jacobi, a retired fundraiser with no family history of diabetes, did not feel concerned. She thought she could lose some weight, but she had normal blood pressure and an active life that included lots of walking and yoga. After trying the drug for a few months, she stopped.

Now no woman has prediabetes. Although Ms. Jacobi didn’t do much to lower her blood sugar and gained a few pounds during the pandemic, her A1C has also fallen to normal levels.

Categories
Health

CDC expands eligibility to everybody 65 and older

The Trump administration on Tuesday issued new guidelines extending coronavirus vaccine eligibility to anyone aged 65 and over, as well as those with comorbid conditions such as diabetes.

States’ focus on vaccinating health care workers and nursing homes has created a bottleneck, a senior administrative official told CNBC, speaking on condition of anonymity ahead of the official announcement.

“States are being told immediately that they need to expand to include those over 65 as well as those under 65 with comorbid conditions,” the official said.

The government will also stop holding back millions of doses reserved for the second round of Pfizer and Moderna two-dose vaccines, the official said, adding that they had released doses that were held in reserve Sunday.

“The states should not wait to complete the prioritization of phase 1a before moving on to broader categories of eligibility,” said Azar on Tuesday the new guidelines. “Think of it like getting on a plane. You may have a sequential order in which you board people. But you don’t wait for literally every person in a group to board before moving on to the next . “

Approximately 53 million Americans aged 65 and over and 110 million people aged 16 to 64 with comorbid conditions can now get the vaccine if each state applies guidelines according to the Centers for Disease Control and Prevention.

President-elect Joe Biden’s transition team announced Friday that his administration plans to release all cans held in reserve.

The Trump administration was due to announce the change at a press conference Tuesday with representatives from Operation Warp Speed, the White House’s vaccination program.

US surgeon general Jerome Adams also confirmed the changes in an interview with Fox News on Tuesday morning.

“We will have clear instructions from the CDC to the governors that they should vaccinate people 65 years of age and older and those under 64 years of age with chronic illness,” he said.

US officials are trying to speed up the pace of vaccinations after a slower-than-expected rollout.

As of Monday morning, more than 25.4 million doses had been distributed in the US, but just over 8.9 million shots had been administered according to CDC data. The number is a far cry from the federal government’s goal of vaccinating 20 million Americans by the end of 2020 and 50 million Americans by the end of this month.

State and local health officials have said they are strapped for cash. They blame insufficient funding and inconsistent communication from the federal government for the slow roll-out.

Democrats and some public health experts have criticized the government for the slow pace. In a letter Monday, Senate Democrats urged the government to make changes, saying it “failed” states by not providing detailed guidance on how to effectively distribute the doses.

The US “cannot afford to have this vaccination campaign continue to be hampered by the lack of planning, communication and leadership we have seen so far,” wrote Chuck Schumer, chairman of the Senate minority, and 44 other Democrats. “The metric that matters, and where we are clearly moving too slowly, is vaccines in weapons.”

In an attempt to speed up the pace of vaccinations, the Secretary for Health and Human Services, Alex Azar, and the Commissioner for Food and Drug Administration, Dr. Stephen Hahn, last week urged states to start vaccinating lower priority groups against Covid-19.

The CDC recommends immunizing health care workers and nursing homes first, but states are free to distribute the vaccine at their discretion. Hahn told reporters that states should give shots to groups that “make sense” such as the elderly, people with pre-existing conditions, police, fire departments and other key workers.

“We heard in the press that some people said, ‘OK, I’m waiting for all of my healthcare workers to be vaccinated. We have a vaccine intake of around 35%.’ I think it makes sense to “extend this to other groups,” said Hahn on Friday. “I would strongly encourage states to give the states the opportunity to be more expansive about who they can give the vaccine to.”

It is unclear whether increasing the eligibility will accelerate the pace of vaccinations. Some states, including Texas and Florida, have already expanded their eligibility criteria.

Categories
Health

HHS secretary recommends states open pictures to older People, weak teams

Minister of Health and Human Services Alex Azar on Wednesday urged states not to micromanage their assigned coronavirus vaccine doses, saying it was better to get the shots off as soon as possible, even if they don’t all have theirs Vaccinate healthcare workers.

“There is no reason states need to complete vaccination of all health care providers before opening vaccinations to older Americans or other high-risk populations,” Azar told reporters during a news conference.

“When they use all of the vaccine that’s allocated, ordered, distributed, shipped, and got it in the arms of the healthcare providers, that’s all great,” he added. “But if for some reason their distribution is difficult and you have vaccines in freezers, then you should definitely open them to people 70 and over.”

US officials are trying to speed up the pace of vaccinations after a slower-than-expected initial rollout. The coronavirus pandemic in the United States continues to grow. The nation has at least 219,200 new Covid-19 cases and at least 2,670 virus-related deaths each day, based on a seven-day average calculated by CNBC using data from Johns Hopkins University.

The Centers for Disease Control and Prevention has provided states with an overview recommending that priority be given to health workers and nursing homes first. However, states may distribute the vaccine at their own discretion.

Azar said Wednesday that states that offer some “flexibility” about who gets the first doses are “the best way to get more shots in the arms, faster”. “Faster administration could save lives now, which means we cannot allow perfect to be the enemy of good,” he said. “Hope is here in the form of vaccines.”

More than 4.8 million people in the United States received their first dose of a coronavirus vaccine at 9 a.m. ET on Tuesday, according to the CDC. The number is a far cry from the federal government’s goal of vaccinating 20 million Americans by the end of 2020 and 50 million Americans by the end of this month.

US officials admitted vaccine distribution was slower than hoped. Dr. Nancy Messonnier, director of the CDC’s National Center for Immunization and Respiratory Diseases, told STAT News Tuesday that she expects the vaccine rollout to accelerate “fairly massively” in the coming weeks.

“It is the beginning of a really complicated task, but one that we are ready for,” she told STAT.

Global health experts had said distributing the vaccines to around 331 million Americans within a few months could prove to be much more complicated and chaotic than originally thought. In addition to making adequate doses, states and territories also need enough needles, syringes, and bottles to complete vaccinations.

The logistics involved in obtaining and administering the vaccine are complex and require special training. For example, Pfizer’s vaccine requires a storage temperature of minus 94 degrees Fahrenheit. Pfizer and Moderna vaccines cannot be re-frozen and must be given at room temperature and within hours, otherwise there is a risk of going bad.

Read More: The Long Road Of The Covid Vaccine: How Doses Get From The Manufacturing Plant To Your Arm

Azar also said the holidays likely played a factor in the slow adoption of vaccines. Healthcare providers knew it would be difficult to hire millions of people for vaccinations by December.

Nearly 20 million doses of vaccine have been dispensed to more than 13,000 locations across the country, General Gustave Perna, who oversees logistics for President Donald Trump’s Operation Warp Speed ​​vaccination program, said during the same meeting.

The vaccine distribution is going “very well,” he said, adding that officials are still working to improve the process. “Our goal is to keep the drum beat constant so that states have a cadence of allocation planning and then the appropriate allocation to the right places as indicated.”

“We are constantly re-evaluating the numbers and making sure that they are distributed in the right places [and] Make sure execution is happening so other decisions can be made about assignments, “he added.

Categories
Business

CDC panel recommends Pfizer Covid vaccine for folks 16 years and older, clearing pivotal hurdle

CDC headquarters in Atlanta

Elijah Nouvelage | Bloomberg via Getty Images

A key panel from the U.S. Centers for Disease Control and Prevention unanimously voted on Saturday to recommend Pfizer-BioNTech’s Covid-19 vaccine for people aged 16 and over. This cleared another crucial hurdle for the drug before the vaccinations begin in the coming days.

The CDC’s Advisory Committee on Immunization Practices, an external group of medical experts advising the agency, voted 11-0 in favor of recommending the vaccine for use in people aged 16 and over under the Food and Drug Administration’s emergency clearance. Three members withdrew due to conflicts.

The recommendation will now be sent to CDC Director Dr. Robert Redfield who must sign out before vaccinations can begin. A CDC spokesman was not immediately available for comment on when Redfield would sign the recommendation.

“This Covid-19 vaccine gives us hope,” said Veronica McNally, ACIP member and assistant dean of experiential education at Michigan State University College of Law. “It’s important to remember that while this vaccine was being developed at an incredible pace and incorporating new technologies, it went through all appropriate channels of regulation and the approval process was transparent.”

Dr. Beth Bell, an ACIP member and clinical professor of global health at the University of Washington, said she recognized people’s concern about this vaccine and new vaccines in general, but added that they were “safely” taking this vaccine when it is she will turn.

“I believe the process we have used here at ACIP to make this decision is transparent, science-based, fair-minded, and for this moment the absolute best we can do,” said Bell .

The vote marked the end of an hour-long meeting during which ACIP members heard presentations from CDC officials on clinical considerations for those vaccinated under the emergency license.

Dr. Sarah Mbaeyi, a CDC doctor, told the agency during a presentation that vaccines should be offered to people “regardless of a history of previous symptomatic or asymptomatic” coronavirus infection. However, Mbaeyi told the panel that a diagnostic or antibody test is not recommended to help decide whether someone should receive the vaccine.

More studies on the vaccine’s safety in pregnant women are ongoing, Mbaeyi said. However, if a pregnant woman is part of a group that is prioritized for the vaccine, Mbaeyi said she could opt for vaccination after making an informed decision with a health care provider.

The public was also asked to share comments and concerns about the vaccine and its dissemination. Claire Hannan, the executive director of the Association of Immunization Managers, told the committee that there needs to be more precise guidance on who is considered an essential worker, as definitions differ across the US.

On December 1, the group voted 13-1 for healthcare workers and residents of long-term care facilities to receive the first doses of vaccine once released for public use. The ACIP emergency meeting, postponed from Sunday to Saturday, followed the FDA’s decision to give Pfizer’s vaccine emergency approval on Friday evening.